Sobel, Jack D.

Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects and therapy

Sobel, J. D., Vazquez, J., Lynch, M., Meriwether, C., & Zervos, M. J. (1993) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 117

Mucosal candidiasis

Vazquez, J. A., & Sobel, J. D. (2002) · Infectious Disease Clinics of North America

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 104

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)

Schwebke, J. R., Sobel, R., Gersten, J. K., Sussman, S. A., Lederman, S. N., Jacobs, M. A., Chappell, B. T., Weinstein, D. L., Moffett, A. H., Azie, N. E., et al. (2022) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 82

Oteseconazole: An Advance in Treatment of Recurrent Vulvovaginal Candidiasis

Sobel, J. D., & Nyirjesy, P. (2021) · Future Microbiology

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 78

A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis

Brand, S. R., Degenhardt, T. P., Person, K., Sobel, J. D., Nyirjesy, P., Schotzinger, R. J., & Tavakkol, A. (2018) · American Journal of Obstetrics and Gynecology

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 78

Fungicidal Activity of Fluconazole against Candida albicans in a Synthetic Vagina-Simulative Medium

Moosa, M.-Y. S., Sobel, J. D., Elhalis, H., Du, W., & Akins, R. A. (2004) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 70

A Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal Candidiasis

Brand, S. R., Sobel, J. D., Nyirjesy, P., Ghannoum, M. A., Schotzinger, R. J., & Degenhardt, T. P. (2021) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 61

Evolution of Antifungal Susceptibility among Candida Species Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis

Vazquez, J. A., Peng, G., Sobel, J. D., Steele‐Moore, L., Schuman, P., Holloway, W., Neaton, J. D., & (CPCRA), T. T. B. C. P. F. C. R. O. A. (2001) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 57

Efficacy and Safety of Oteseconazole in Recurrent Vulvovaginal Candidiasis

Sobel, J. D., Donders, G., Degenhardt, T., Person, K., Curelop, S., Ghannoum, M., & Brand, S. R. (2022) · NEJM Evidence

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 55

Prognosis and Long-Term Outcome of Women With Idiopathic Recurrent Vulvovaginal Candidiasis Caused by Candida albicans

Collins, L. M., Moore, R., & Sobel, J. D. (2020) · Journal of Lower Genital Tract Disease

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 55

Evolution of Vaginal Candida Species Recovered from Human Immunodeficiency Virus‐Infected Women Receiving Fluconazole Prophylaxis: The Emergence of Candida glabrata?

Vazquez, J. A., Sobel, J. D., Peng, G., Steele‐Moore, L., Schuman, P., Holloway, W., Neaton, J. D., & (CPCRA), T. T. B. C. P. F. C. R. I. A. (1999) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 51

Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis

Sobel, J. (2013) · Patient Preference and Adherence

Reproductive tract infections researchAntifungal resistance and susceptibility

Cited by 48

Oral Ibrexafungerp: An Investigational Agent for the Treatment of Vulvovaginal Candidiasis

Azie, N., Angulo, D., Dehn, B., & Sobel, J. D. (2020) · Expert Opinion on Investigational Drugs

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 46

Management of recurrent vulvovaginal candidiasis: Unresolved issues

Sobel, J. D. (2006) · Current Infectious Disease Reports

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 36

Long-Term Outcomes of Women With Recurrent Vulvovaginal Candidiasis After a Course of Maintenance Antifungal Therapy

Crouss, T., Sobel, J. D., Smith, K., & Nyirjesy, P. (2018) · Journal of Lower Genital Tract Disease

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 29

Genital candidiasis

Sobel, J. D. (2014) · Medicine

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 24

New Antifungals for Vulvovaginal Candidiasis: What Is Their Role?

Sobel, J. D. (2023) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 23

The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women.

Nijhawan, A. E., DeLong, A. K., Celentano, D. D., Klein, R. S., Sobel, J. D., Jamieson, D. J., & Cu-Uvin, S. (2011) · Sexually Transmitted Diseases

Reproductive tract infections researchCriminal Justice and Corrections Analysis

Cited by 22

Data on Safety of Intravaginal Boric Acid Use in Pregnant and Nonpregnant Women: A Narrative Review

Mittelstaedt, R., Kretz, A., Levine, M., Handa, V. L., Ghanem, K. G., Sobel, J. D., Powell, A., & Tuddenham, S. (2021) · Sexually Transmitted Diseases

Reproductive tract infections researchAntifungal resistance and susceptibility

Cited by 14